Temporal Arteritis: Clinical Trials

1 trial for Temporal Arteritis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Terminated 1
Phase 21Terminated 1

Follow Temporal Arteritis: new trials by email Literature Review of Temporal Arteritis trials Research Report on Temporal Arteritis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Ustekinumab for the Treatment of Giant Cell Arteritis
Ustekinumab, Prednisone - Giant Cell Arteritis, Temporal Arteritis
Phase 1 / Phase 2TerminatedMassachusetts General Hospital132016-12-012020-06-12

Narrower conditions

Giant Cell Arteritis (1)

Broader conditions

Arteritis (1)  ·  Autoimmune Diseases (1)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Brain Diseases (1)  ·  Cardiovascular Diseases (1)  ·  Central Nervous System Diseases (1)  ·  Cerebrovascular Disorders (1)  ·  Immune System Diseases (1)  ·  Nervous System Diseases (1)  ·  Skin Diseases (1)  ·  Skin Diseases, Vascular (1)  ·  Skin and Connective Tissue Diseases (1)  ·  Vascular Diseases (1)  ·  Vasculitis (1)  ·  Vasculitis, Central Nervous System (1)

Interventions

Prednisone (1)  ·  Ustekinumab (1)

Sponsors

Massachusetts General Hospital (1)

Countries

United States (1)

Results publications

PMID 32248659